Fractal Investments’s Chemours CC Stock Holding History

Fractal Investments’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,938	Closed	-$233K	–	121
2021 Q4	$233K	Buy	+6,938	New	+$216K	0.08%	111

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fractal Investments's CC Position: Q1 2022 in Review

Fractal Investments sold out of Chemours (CC) in Q1 2022, closing a stake of 6,938 shares — an estimated $233K sold.

Fractal Investments first reported a position in CC in Q4 2021 and held it in 1 quarter. The position peaked at $233K in Q4 2021. 481 funds tracked by Wall St. Rank hold CC as of Q1 2022.

Fractal Investments reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
Fractal Investments sold 6,938 Chemours shares in Q1 2022, an estimated $233K.
Fractal Investments first reported a position in Chemours in Q4 2021 and held it in 1 quarter.
Fractal Investments's Chemours position peaked at $233K in Q4 2021.
481 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Fractal Investments's 13F filing for Q1 2022, filed 20 Apr 2022.